Latest The Andersons (ANDE) Headlines Insider Trading

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Latest The Andersons (ANDE) Headlines

Insider Trading Alert - ANDE, BAS And HOG Traded By Insiders
at The Street - Wed Mar 05, 9:45AM CST
Stocks with insider trader activity include ANDE, BAS and HOG

Insider Trading Alert - AGCO, HBAN And ANDE Traded By Insiders
at The Street - Tue Mar 04, 10:00AM CST
Stocks with insider trader activity include AGCO, HBAN and ANDE

The Andersons, Inc. Declares its 70th Consecutive Dividend
PR Newswire - Fri Feb 28, 2:05PM CST
The Andersons, Inc. (NasdaqGS: ANDE) today announced a post-split second quarter 2014 cash dividend of 11 cents ($0.11) per share payable April 22, 2014, to shareholders of record on April 1, 2014. The dividend reflects the three-for-two stock split that went into effect on February 19, 2014. Had the split not occurred, the dividend rate would have been $0.165 per share, matching the Company's first quarter dividend.

Insider Trading Alert - MMM, ANDE And SHW Traded By Insiders
at The Street - Tue Feb 25, 10:15AM CST
Stocks with insider trader activity include MMM, ANDE and SHW

Nasdaq stocks posting largest percentage decreases
AP - Wed Feb 12, 5:04PM CST
NEW YORK (AP) — A look at the 10 biggest percentage decliners on Nasdaq at the close of trading:

The Andersons, Inc. Clarifies Post-split EPS
PR Newswire - Wed Feb 12, 11:40AM CST
The Andersons, Inc. (Nasdaq: ANDE) today clarified media reports regarding its Fourth Quarter 2013 and Full-Year results announced Tuesday.

Andersons Rises on Record Q4 Earnings - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Feb 12, 9:30AM CST
Andersons' fourth-quarter earnings fell short of the Zacks Consensus Estimate.

Andersons Down to Neutral - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Feb 11, 6:05PM CST
On Feb 6, we downgraded our recommendation on Andersons from Outperform to Neutral.

The Andersons, Inc. Reports Fourth Quarter & Full Year Results
PR Newswire - Tue Feb 11, 3:01PM CST
The Andersons, Inc. (Nasdaq: ANDE) today announced net income attributable to the company of $89.9 million, or $3.18 per diluted share, on $5.6 billion in revenues. It should be noted that all prior period per share data in this release has been adjusted to reflect the company's February 2014 three-for-two stock split. Last year earnings were $79.5 million, or $2.82 per diluted share on revenues of $5.3 billion. The company earned $30.7 million in the fourth quarter of 2013, or $1.08 per diluted share, on revenues of $1.6 billion. In the same three month period of 2012, the company reported net income of $15.0 million, or $0.53 per diluted share, on revenues of $1.7 billion.

Upgrade Alert for Andersons (ANDE)
Comtex SmarTrend(R) - Fri Feb 07, 7:12AM CST
Andersons (NASDAQ:ANDE) was upgraded from Equal Weight to Overweight at Stephens today. The stock closed yesterday at $84.98 on volume of 335,000 shares, above average daily volume of 189,000. Based on a current price of $84.98, Andersons is currently 7.0% above its average consensus analyst price target of $79.00. The stock should find resistance at its 50-day moving average (MA) of $85.81, as well as support at its 200-day MA of $68.78.

'Mad Money' Lightning Round: We Don't Want Molycorp
at The Street - Thu Feb 06, 5:00AM CST
Cramer likes Palo Alto Networks over FireEye and Linn Energy over Breitburn Energy Partners.

Jim Cramer's 'Mad Money' Recap: A Matter of Distrust
at The Street - Wed Feb 05, 6:51PM CST
Cramer says there are two sides to every earnings report, and the ugly side is where investors are focusing.

The Andersons to Reduce Investment in Lansing Trade Group
PR Newswire - Wed Jan 22, 8:00AM CST
The Andersons, Inc. (Nasdaq: ANDE) announces today that it has entered into an agreement with Lansing Trade Group, LLC (LTG) for a partial redemption of The Andersons' equity investment in LTG.

CF Industries Reaches 52-Week High - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Jan 13, 11:00AM CST
Shares of CF Industries hit a new 52-week high of $246.95 on Jan 10 and eventually closed at $246.16.

Monsanto Q1 Beats on Earnings and Revs - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Jan 08, 9:23AM CST
Monsanto beats the Zacks Consensus Estimate for earnings and revenues in the first quarter of fiscal 2014.

Will Monsanto (MON) Disappoint This Earnings Season? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Jan 06, 9:00AM CST
Monsanto is set to report fiscal first-quarter 2014 results on Jan 8 before the market opens.

2013 Highlights, Conference Participation, Settlement, Results Schedule, and Stock Split - Research Report on Starbucks, Chipotle, ADM, Wendy's, and The Andersons
PR Newswire - Mon Jan 06, 7:00AM CST
Editor Note: For more information about this release, please scroll to bottom.

Molycorp, Inc. (MCP) Surges: Stock Moves 11.9% Higher - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Jan 03, 8:21AM CST
Molycorp, Inc. (MCP) was a big mover last session, as the company saw its shares rise by almost 12% on the day.

Gastar Exploration (GST) Jumps: Stock Rises 8.5% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Jan 02, 8:18AM CST
Gastar Exploration, Inc. (GST) was a big mover last session, as the company saw its shares rise by over 8% on the day.

The Andersons (ANDE) Stock Research Links

ANDE Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Capricor Faces Lawsuit: Investors Should Take Note

Updated Category News Views 4

Capricor Therapeutics: A Rough Road Ahead If you've got skin in the game with Capricor Therapeutics, these latest developments might have you feeling a bit queasy. Forget the greasy diner fare today; this situation calls for some serious contemplation and maybe a bit of antacid. Over at NASDAQ:CAPR, the air is hot with allegations, stock price nosedives, and looming legal...

Continue Reading
CAPR Faces Lawsuit and FDA Delay: Investor Alert

Updated Category News Views 0

Trouble Brewin' for Capricor Investors Buckle up, folks. Capricor Therapeutics (NASDAQ: CAPR) is caught in a storm, facing not just the lengthy arm of law with a securities class action, but also a seemingly endless wait with the FDA's decision on their lead product. We're talking serious implications for anyone with skin in the game. The FDA's Delayed Blessing So the...

Continue Reading
Travel Smart: Support Wildlife, Avoid Exploitation

Updated Category News Views 1

Rethink Wildlife Tourism for Ethical Travel You ever stopped to think about what those so-called wildlife attractions are really selling? It’s a feel-good illusion wrapped up in exploitation. Travelers often see animals as part of the backdrop of their holiday stories, but the reality is far from picturesque. Behind the photo ops, there's typically a grim story of...

Continue Reading
ECRI Welcomes Safety Expert Meshkati to Its Board

Updated Category News Views 1

The Safety Maverick Steps into Healthcare They've gone and done it—appointed a rockstar of systems safety to ECRI's Board of Trustees. Professor Najmedin Meshkati, who's practically been around every major industrial accident of the past few decades, is about to shake things up. Imagine the guy who's dissected calamities like the BP Texas City Refinery explosion and the...

Continue Reading
United Imaging's CE Mark Ignites CT Innovation in Europe

Updated Category News Views 5

United Imaging's Big Leap in CT Technology Listen up, folks. United Imaging just got the go-ahead to shake things up in Europe with their dual wide-coverage CT family. We're talking about the uCT SiriuX and the even more amped-up uCT SiriuX Ultrix. They’ve snagged the CE mark, a passport to roll out these impressive machines across the continent. Revolutionizing...

Continue Reading
Cypress Wood's Resilience in Louisiana's Humidity

Updated Category News Views 1

Timber Talk with Wes McAdams Diving into the nitty-gritty of building materials isn't everyone's cup of tea, but when you live in a place like Baton Rouge, understanding what stands up to the swampy summer heat is plain survival. The main focus? Cypress wood. Now, Wes McAdams from Cajun Cypress throws his hat into the ring, shedding some light on why cypress might just be...

Continue Reading
Drones Propel Precision Agriculture Market's Skyrocketing Growth

Updated Category News Views 2

Transforming Fields with a Bird's Eye View The old-school way of agricultural surveying is about as appealing as a broken plow in a rainstorm. Trudging across miles of farmland, hoping to spot issues before they turn into wallet-drainers—who's got time for that? Enter drones, the buzzing saviors of the modern farm. These high-tech marvels, loaded with multispectral and...

Continue Reading
Innventure Faces Securities Lawsuit After 74% Stock Drop

Updated Category News Views 2

Innventure's Stunning Plummet: A Lesson in Investor Caution Investors in Innventure, Inc. (NASDAQ: INV) got a harsh reminder of the market's volatility when the company's stock value nosedived by a staggering 74%. From May 27, 2026, just before the forensic bombshell by Morpheus Research, to August 14, 2026, Innventure's stock went from shaky to downright catastrophic....

Continue Reading
Aurra Markets Wins 'Most Transparent Broker' Award 2026

Updated Category News Views 2

Spotlight on Transparency in Trading Alright, so Aurra Markets snagged the 'Most Transparent Broker' award at the Money Expo in Mumbai this year. From the greasy streets of trading floors to the polished halls of Jio World Convention Centre, transparency is one of those golden words you hear tossed around, but like finding a needle in a haystack, it’s not always easy to...

Continue Reading
Eluvio's Broadcast Revolution: Zero-Copy AI Streaming

Updated Category News Views 2

The Game-Changing Shift in Broadcast Tech Eluvio's latest reveal at IBC 2026 shows they've taken the gloves off in the broadcast arena. They're pitching an all-in-one Global Broadcast Fabric that's turning heads with its zero-copy distribution and inline AI capabilities. No more dilly-dallying with satellites or cumbersome cloud solutions. Instead, they've cut right to...

Continue Reading

Top 5 Most Recently Viewed Articles

Huron Appoints Hope Katz as New General Counsel

Updated Category News Views 129

Huron Welcomes Hope Katz as General Counsel In an exciting development within the legal realm, globe-spanning professional services firm Huron (NASDAQ: HURN) has recently made a significant addition to its executive team. The firm has elevated Hope Katz to the position of executive vice president, general counsel, and corporate secretary, with her new role set to commence...

Continue Reading
Aston Martin's Growth Focus: Key Strategies and Insights Unveiled

Updated Category News Views 164

Aston Martin's Growth Focus: Key Strategies and Insights Unveiled Aston Martin's CEO Adrian Hallmark and CFO Doug Lafferty recently provided valuable insights into the company’s financial performance and future ambitions during an earnings call. Hallmark, who has settled into his role, emphasized the importance of the newly launched Vanquish and shared his excitement...

Continue Reading
Investigation into Possible Violations at Zuora and Others

Updated Category News Views 161

Halper Sadeh LLC's Investigation into Companies Halper Sadeh LLC, an esteemed law firm focused on investor rights, is currently exploring potential violations of federal securities laws involving several companies, including notable names like Zuora, Profire Energy, Future Vision II Acquisition Corp., and Hudson Acquisition I Corp. Details of the Investigations The...

Continue Reading
Navigating Dow Inc. Securities Lawsuit: Key Information for Investors

Updated Category News Views 183

Understanding the Dow Inc. Securities Lawsuit Investors have been notified of an important class action lawsuit involving Dow Inc. (NYSE: DOW). This legal action has been initiated by Levi & Korsinsky, LLP, aimed at protecting the rights of shareholders. This article will break down the essential aspects of the lawsuit and the implications for Dow investors. Who is...

Continue Reading
FDA Clears Momentis Anovo®: Revolution in Surgery

Updated Category News Views 7

The Evolution of Robotic Surgery There's a tide coming in the world of surgery, and Momentis Surgical is right at the crest. This isn't just another corporate cheer; we're talking about the FDA giving a green light to Momentis Surgical's Anovo® System. With this nod, the platform isn't bound by the chains of traditional robotic surgery systems. We're now looking at the...

Continue Reading